Journal of Applied Physiology Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Appl Physiol (December 21, 2006). doi:10.1152/japplphysiol.00815.2006
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
102/4/1502    most recent
00815.2006v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonnet, N.
Right arrow Articles by Courteix, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonnet, N.
Right arrow Articles by Courteix, D.
Submitted on July 25, 2006
Accepted on December 18, 2006

Doping dose of Salbutamol and exercise: deleterious effect on cancellous and cortical bones in adult rats

Nicolas Bonnet1*, Claude Laurent Benhamou1, Helene Beaupied1, Norbert Laroche2, Laurence Vico2, Eric Dolleans1, and Daniel Courteix1

1 inserm U658, orléans, France
2 inserm E366, Saint Etienne, France

* To whom correspondence should be addressed. E-mail: nicolas.bonnet15{at}wanadoo.fr.

Animal studies suggest that bone remodelling is under {beta}-adrenergic control via the sympathetic nervous system. To our knowledge, the impact of doping {beta}2 agonist substances, at doping doses, has never been studied on adult rats. The purpose of this study was to examine the effects of Salbutamol injections without exercise or combined with treadmill exercise on trabecular and cortical bone in adult rats. Adult female Wistar rats (36 weeks of age, n=56) received a subcutaneous injection of Salbutamol (SHAM SAB, 3mg/kg/day, 5 days/week) or vehicle (SHAM) with or without subsequent treadmill exercise (13m/min, 60min/day, 5 days/week) for 10 weeks. Tibial and femoral BMD were analyzed by Dual energy X-ray Absorptiometry. At death, microcomputed tomography was performed to study metaphysic trabecular bone structure. Histomorphometric analysis was performed to assess bone cell activities. After 10 weeks, SAB rats presented a lower BMD increase (SAB: +3.3% vs SHAM: +12.4%, p<0.05), an alteration of the trabecular parameters and an increased bone resorption compared to the control group. The negative effect on bone architecture in SAB-treated groups persisted even with treadmill exercise. These results confirm the deleterious effect observed during chronic treatment, of {beta}2 agonists on bone mass, and describe its consequences on bone mechanical properties in adult rats. Bone loss occurred independently of SAB-induced muscle mass anabolism and was equally severe in sedentary and exercising rats, despite a beneficial effect of exercise on the extrinsic and intrinsic energy to ultimate. These bone effects may have important consequences in athletes using Salbutamol as doping substance.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
N. Bonnet, N. Laroche, H. Beaupied, L. Vico, E. Dolleans, C. L. Benhamou, and D. Courteix
Doping dose of salbutamol and exercise training: impact on the skeleton of ovariectomized rats
J Appl Physiol, August 1, 2007; 103(2): 524 - 533.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1948 by the American Physiological Society.